{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T12:22:45Z","timestamp":1787660565338,"version":"build-2736575974"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.pharma.2026.08.002","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T05:52:58Z","timestamp":1785995578000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Analyse descriptive transversale de la forme et du contenu de formulaires d\u2019acc\u00e8s \u00e0 des m\u00e9dicaments de sp\u00e9cialit\u00e9 via des programmes de soutien aux patients"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-2207-8891","authenticated-orcid":false,"given":"Louise","family":"Lardeux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Delisle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"B\u00e9dard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fedor","family":"Jila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6623-4967","authenticated-orcid":false,"given":"Jean-Fran\u00e7ois","family":"Bussi\u00e8res","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharma.2026.08.002_bib0095","unstructured":"Ifis Groupe. Construire un programme d\u2019accompagnement patient (PSP). [internet] [cit\u00e9 le 3\u00a0octobre 2025]. Disponible sur\u00a0: https:\/\/www.ifis.fr\/formations-medicament\/psp."},{"key":"10.1016\/j.pharma.2026.08.002_bib0100","unstructured":"Association Qu\u00e9b\u00e9coise des pharmaciens propri\u00e9taires. M\u00e9dicaments de sp\u00e9cialit\u00e9 et programmes de soutien aux patients. [internet] [cit\u00e9 le 5\u00a0d\u00e9cembre 2025]. Disponible sur\u00a0: https:\/\/www.monpharmacien.ca\/medicaments-de-specialite\/."},{"key":"10.1016\/j.pharma.2026.08.002_bib0105","unstructured":"L\u00e9giFrance. Loi no\u00a02011-2012\u00a0du 29\u00a0d\u00e9cembre 2011\u00a0relative au renforcement de la s\u00e9curit\u00e9 sanitaire du m\u00e9dicament et des produits de sant\u00e9. [internet]. [cit\u00e9 le 30\u00a0d\u00e9cembre 2011]. Disponible sur\u00a0: https:\/\/www.legifrance.gouv.fr\/jorf\/id\/JORFTEXT000025053440\/."},{"key":"10.1016\/j.pharma.2026.08.002_bib0110","unstructured":"L\u00e9giFrance. Loi no\u00a02018-493\u00a0du 20\u00a0juin 2018\u00a0relative \u00e0 la protection des donn\u00e9es personnelles. [internet]. [cit\u00e9 le 21\u00a0juin 2018]. Disponible sur\u00a0: https:\/\/www.legifrance.gouv.fr\/jorf\/id\/JORFTEXT000037085952."},{"issue":"46","key":"10.1016\/j.pharma.2026.08.002_bib0115","doi-asserted-by":"crossref","first-page":"E1565","DOI":"10.1503\/cmaj.230841","article-title":"Prevalence and nature of manufacturer-sponsored patient support programs for prescription drugs in Canada: a cross-sectional study","volume":"195","author":"Grundy","year":"2023","journal-title":"CMAJ"},{"key":"10.1016\/j.pharma.2026.08.002_bib0120","unstructured":"L\u00e9gisQu\u00e9bec. Loi sur la protection des renseignements personnels dans le secteur priv\u00e9. [internet] [cit\u00e9 le 1er septembre 2025]. Disponible sur\u00a0: https:\/\/www.legisquebec.gouv.qc.ca\/fr\/document\/lc\/p-39.1."},{"issue":"4","key":"10.1016\/j.pharma.2026.08.002_bib0125","first-page":"179","article-title":"Comparaison du r\u00f4le et des perceptions de pharmaciens hospitaliers dans la dispensation de certaines th\u00e9rapies orales ambulatoires en oncologie en Am\u00e9rique du Nord et en Europe\u00a0: une \u00e9tude exploratoire","volume":"41","author":"Jacolin","year":"2022","journal-title":"J Pharm Clin"},{"issue":"2","key":"10.1016\/j.pharma.2026.08.002_bib0130","first-page":"70","article-title":"\u00c9mergence des pharmacies de sp\u00e9cialit\u00e9s\u00a0: r\u00e9flexion sur les possibilit\u00e9s et les d\u00e9fis","volume":"57","author":"Marc","year":"2024","journal-title":"Pharmactuel"},{"key":"10.1016\/j.pharma.2026.08.002_bib0135","unstructured":"Sant\u00e9 Canada. Ligne directrice sur la pr\u00e9sentation des plans de gestion des risques\u00a0: Aper\u00e7u [Internet]. 2025 [cit\u00e9 9\u00a0oct 2025]. Disponible sur\u00a0: https:\/\/www.canada.ca\/fr\/sante-canada\/services\/medicaments-produits-sante\/rapports-publications\/medeffet-canada\/ligne-directrice-presentation-plans-gestion-risques-politique-apercu.html."},{"key":"10.1016\/j.pharma.2026.08.002_bib0140","unstructured":"Association qu\u00e9b\u00e9coise des coordonnateurs d\u2019acc\u00e8s aux m\u00e9dicaments d\u2019oncologie. \u00c0 propos. [internet]. [cit\u00e9 le 5\u00a0d\u00e9cembre 2025]. Disponible sur\u00a0: https:\/\/aqcamo.ca\/."},{"key":"10.1016\/j.pharma.2026.08.002_bib0145","doi-asserted-by":"crossref","first-page":"11877","DOI":"10.3389\/jpps.2023.11877","article-title":"Data collection within patient support programs in Canada and implications for real-world evidence generation: the authors\u2019 perspective","volume":"26","author":"Wills","year":"2023","journal-title":"J Pharm Pharm Sci"},{"issue":"6","key":"10.1016\/j.pharma.2026.08.002_bib0150","doi-asserted-by":"crossref","first-page":"417","DOI":"10.46747\/cfp.7106417","article-title":"Administrative burden in primary care","volume":"71","author":"Storseth","year":"2025","journal-title":"Can Fam Physician"},{"issue":"7","key":"10.1016\/j.pharma.2026.08.002_bib0155","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1093\/jamia\/ocaf087","article-title":"The administrative burden of medication affordability resources: an environmental scan with implications for health informatics to advance health equity","volume":"32","author":"Antonio","year":"2025","journal-title":"J Am Med Inform Assoc JAMIA"},{"issue":"11\u201312","key":"10.1016\/j.pharma.2026.08.002_bib0160","doi-asserted-by":"crossref","first-page":"685","DOI":"10.46747\/cfp.701112685","article-title":"Consent forms used by patient assistance programs raise privacy concerns","volume":"70","author":"Dix-Cooper","year":"2024","journal-title":"Can Fam Physician"},{"issue":"4","key":"10.1016\/j.pharma.2026.08.002_bib0165","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s41649-024-00283-8","article-title":"Cross-jurisdictional data transfer in health research: stakeholder perceptions on the role of law","volume":"16","author":"Chan","year":"2024","journal-title":"Asian Bioeth Rev"},{"issue":"1","key":"10.1016\/j.pharma.2026.08.002_bib0170","doi-asserted-by":"crossref","first-page":"lsaa055","DOI":"10.1093\/jlb\/lsaa055","article-title":"International transfers of health data between the EU and USA: a sector-specific approach for the USA to ensure an \u201cadequate\u201d level of protection","volume":"7","author":"Bradford","year":"2020","journal-title":"J Law Biosci"},{"key":"10.1016\/j.pharma.2026.08.002_bib0175","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.meddro.2018.08.001","article-title":"La protection des donn\u00e9es personnelles des patients face \u00e0 la modernisation de notre syst\u00e8me de sant\u00e9","volume":"2019","author":"Siranyan","year":"2019","journal-title":"Med Droit"},{"issue":"2","key":"10.1016\/j.pharma.2026.08.002_bib0090","doi-asserted-by":"crossref","first-page":"e0295226","DOI":"10.1371\/journal.pone.0295226","article-title":"Real-World evidence revelations: The potential of patient support programmes to provide data on medication usage","volume":"19","author":"Palffy","year":"2024","journal-title":"PLoS One"}],"container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450926001173?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450926001173?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T11:34:40Z","timestamp":1787657680000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003450926001173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":18,"alternative-id":["S0003450926001173"],"URL":"https:\/\/doi.org\/10.1016\/j.pharma.2026.08.002","relation":{},"ISSN":["0003-4509"],"issn-type":[{"value":"0003-4509","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analyse descriptive transversale de la forme et du contenu de formulaires d\u2019acc\u00e8s \u00e0 des m\u00e9dicaments de sp\u00e9cialit\u00e9 via des programmes de soutien aux patients","name":"articletitle","label":"Article Title"},{"value":"Annales Pharmaceutiques Fran\u00e7aises","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharma.2026.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Acad\u00e9mie Nationale de Pharmacie. Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}